Early Stages of Mesothelioma, Screening and Biomarkers

Sonja Klebe, Douglas Henderson

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    12 Citations (Scopus)


    The early diagnosis of mesothelioma is notoriously difficult, both from a clinical and pathological perspective. Patients often undergo several medical investigations without definitive diagnosis. The discovery of biomarkers that can be assessed in pleural effusions, histological samples, and serum may assist with the difficult early diagnosis of mesothelioma. In this chapter we focus on those markers that have been examined in the setting of either early diagnosis of mesothelioma in symptomatic individuals or that have been proposed as suitable for screening of asbestos-exposed individuals, with an emphasis on cytology and histology.

    Original languageEnglish
    Title of host publicationMalignant Mesothelioma
    EditorsAndrea Tannapfel
    Number of pages25
    ISBN (Print)9783642108617
    Publication statusPublished - 2011

    Publication series

    NameRecent Results in Cancer Research
    ISSN (Print)0080-0015


    Dive into the research topics of 'Early Stages of Mesothelioma, Screening and Biomarkers'. Together they form a unique fingerprint.

    Cite this